Evidence map›Paper›PMID 29731815›Full record

ArticleExperimental and therapeutic medicine2018

Oral lichen planus and malignant transformation: The role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential.

Eduardo Augusto Rosa, Aura Maria Hurtado-Puerto, Denise Pinheiro Falcão, Aline Patricia Brietzke, Luiz Eduardo De Almeida Prado Franceschi, Florlorêncio Figueiredo Cavalcanti Neto, Valdenize Tiziane, Fabiana Pirani Carneiro, Evelyn Mikaela Kogawa, Heitor Moreno and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Autoimmune disease and oral squamous cell carcinoma: A systematic review.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2021
    Pooled it
  3. Different Approaches to Oral Lichen Planus Treatment: A Narrative Review.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. HPV related p16BMC oral health · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Immunoexpression of oral brush biopsy enhances the accuracy of diagnosis for oral lichen planus and lichenoid lesions.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Oral lichen planus - case report.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Eduardo Augusto RosaPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Aura Maria Hurtado-PuertoLaboratory for Neuropsychiatry and Neuromodulation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.
Denise Pinheiro FalcãoPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Aline Patricia BrietzkeLaboratory of Pain and Neuromodulation at Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90035-903, Brazil.
Luiz Eduardo De Almeida Prado FranceschiDepartment of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Florlorêncio Figueiredo Cavalcanti NetoPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Valdenize TizianeCenter for Learning and Research, Brasília Children's Hospital, Brasília 70910-90, Brazil.
Fabiana Pirani CarneiroPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Evelyn Mikaela KogawaPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Heitor MorenoLaboratory of Cardiovascular Pharmacology, School of Medical Sciences, University of Campinas, Campinas, São Paulo 13083-970, Brazil.
Rivadávio Fernandes Batista AmorimPost-Graduation Program in Medical Sciences, Department of Pathology, School of Medicine, University of Brasília, Brasília 70910-900, Brazil.
Massachusetts General Hospital · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association of oral lichen planus (OLP) lesions with malignant transformation risk has remained a controversial topic and is of clinical importance. Therefore, the present study evaluated the expression levels of p16, Ki-67, budding uninhibited by benzimidazoles 3 (Bub-3) and sex-determining region Y-related high mobility group box 4 (SOX4), and their roles as precancerous biomarkers in OLP. A retrospective study was performed, in which tissue blocks of OLP, oral dysplasia (OD), cutaneous lichen planus (CLP) and oral fibrous hyperplasia (OFH) were used (n=120). A positivity index (PI) for p16, BUB3, Ki-67 and SOX4 expression was calculated in each group. The PI for p16 was 20.65% for OLP, 7.85% for OD, 86.59% for CLP and 11.8% for OFH, and the difference between these groups was statistically significant (P<0.001). PIs of Ki-67 were indicated as 11.6% for OLP, 14.4% for OD, 8.24% for CLP and 5.5% for OFH, and a statistically significant difference was observed between the groups (P<0.001). Notably, the expression levels of BUB3 were not statistically different among groups. The highest expression levels of SOX4 were identified in CLP (P<0.001 vs. OLP/CLP; P=0,001 vs. CLP/OD). The determined expression levels of p16 and Ki-67 suggest that specific OLP lesions may have an intermediate malignant potential and should be carefully followed up. The intense SOX4 staining in CLP indicated a different proliferation pattern of epithelium compared with oral mucosa cells. These findings suggest that SOX4 expression may also be associated with the different clinical courses of OLP and CLP.

Indexed as

biomarkersBub-3Ki-67 antigenlichen planusoral lichen planusp16 (INK4A)precancerous conditionsSOX4

Identifiers

PMID29731815
PMCPMC5920964
OpenAlexW2789450765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.